DEFA14A: Amaze Holdings Reconvenes Special Stockholder Meeting

Sentiment:

Special Meeting Update


Amaze Holdings, Inc. announced the reconvening of its special stockholder meeting to vote on the issuance of common stock exceeding NYSE American exchange caps.

Delay expectedThe Special Meeting of Stockholders, originally scheduled for December 10, 2025, was adjourned due to the absence of a quorum.The meeting has been rescheduled to February 4, 2026, delaying the vote on the proposed share issuance.
Capital raiseStockholders will vote on the issuance of shares of common stock upon conversion of senior secured original issue discount convertible notes.This issuance is in excess of the 19.9% exchange cap, requiring stockholder approval under NYSE American Company Guide Section 713(a) and 713(b).
Worse than expectedThe initial Special Meeting on December 10, 2025, was adjourned because a quorum was not present, indicating a failure to meet the required attendance for conducting business.

Summary

  • Amaze Holdings, Inc. (AMZE) reconvened its Special Meeting of Stockholders, originally scheduled for December 10, 2025, which was adjourned due to the absence of a quorum.
  • The Special Meeting will now be held on February 4, 2026, at 11:00 a.m. Eastern Time.
  • Stockholders will vote to approve the issuance of common stock upon conversion of senior secured original issue discount convertible notes.
  • This approval is necessary to comply with Section 713(a) and Section 713(b) of the NYSE American Company Guide, as the issuance exceeds the 19.9% exchange cap.
  • Stockholders who have already cast their votes do not need to take further action unless they wish to change or revoke their prior proxy or voting instructions.
  • The Company's Board of Directors recommends that stockholders vote FOR the proposals.

Sentiment

Score: 5

Explanation: The filing is primarily procedural and neutral in tone. The initial adjournment due to lack of quorum is a minor negative, but the company is taking appropriate steps to resolve it. The underlying issue of exceeding the exchange cap for convertible notes could be viewed with mixed sentiment depending on the investor's perspective on potential dilution versus debt management.

Positives

  • The company is actively addressing compliance requirements with NYSE American rules regarding share issuance.
  • The Board of Directors recommends voting FOR the proposals, indicating internal alignment on the strategic direction.

Negatives

  • The initial Special Meeting was adjourned due to a lack of quorum, which could indicate shareholder apathy or challenges in proxy solicitation.

Risks

  • Potential dilution for existing shareholders if the issuance of common stock upon conversion of senior secured original issue discount convertible notes is approved and executed.
  • Risk of non-compliance with NYSE American Company Guide if stockholder approval for the share issuance exceeding the 19.9% exchange cap is not obtained.

Future Outlook

The company plans to proceed with the reconvened Special Meeting on February 4, 2026, to seek stockholder approval for the issuance of common stock related to convertible notes, ensuring compliance with NYSE American rules. This action is critical for managing its senior secured original issue discount convertible notes.

Management Comments

  • The Company's Board of Directors recommends that you vote FOR the proposals identified in the Company's definitive proxy statement for the Special Meeting.

Industry Context

This announcement is a company-specific procedural event related to corporate governance and financing, rather than a reflection of broader industry trends. It highlights the ongoing need for companies to manage their capital structure and comply with exchange listing requirements.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Shareholder Vote RequirementSeeking stockholder approval for the issuance of common stock upon conversion of senior secured original issue discount convertible notes, which exceeds the 19.9% exchange cap under NYSE American Company Guide Sections 713(a) and 713(b).February 4, 2026 (if approved)Ensures compliance with exchange listing rules and facilitates the conversion of outstanding convertible notes, potentially leading to dilution for existing shareholders.

Stakeholder Impact

  • Shareholders: Potential for dilution from the issuance of common stock upon conversion of senior secured original issue discount convertible notes. Required to participate in a significant corporate governance vote.

Next Steps

  • Send a notice of the reconvened meeting date and time to all stockholders of record as of November 7, 2025.
  • Hold the reconvened Special Meeting on February 4, 2026, at 11:00 a.m. Eastern Time.
  • Stockholders to vote on the approval of common stock issuance upon conversion of senior secured original issue discount convertible notes.

Key Dates

DateDescription
November 7, 2025Record date for stockholders eligible to vote at the Special Meeting.
December 10, 2025Original date of the Special Meeting, which was convened and immediately adjourned due to lack of quorum.
December 12, 2025Date of the press release and Current Report on Form 8-K announcing the reconvened meeting.
February 4, 2026Reconvened date for the Special Meeting of Stockholders at 11:00 a.m. Eastern Time.

Recommendation

hold

This filing is procedural, addressing a compliance issue related to past financing. While the initial quorum failure is a minor concern, the company is taking steps to rectify it. The vote on share issuance for convertible notes introduces potential dilution, which is a factor to monitor, but it is also a mechanism for managing debt. Investors should hold and await the outcome of the vote and further financial disclosures before making significant investment decisions.

Keywords

Amaze Holdings, AMZE, Special Meeting, Stockholders, Proxy, NYSE American, Convertible Notes, Share Issuance, Quorum, Corporate Governance, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.